Weizmann Institute scientists develop a potential future treatment for myasthenia gravis

Weizmann Institute researchers have developed an effective treatment, administered through the nose, for a myasthenia gravis-like disease in rats, according to a report in the July 6 issue of the Proceedings of the National Academy of Sciences (PNAS).

The new approach used in the study may serve as a basis for treating myasthenia gravis in humans. "More studies will be necessary before applying our approach in clinical trials, but we have good reason to believe that an effective treatment for human patients can now be developed," said research team leader Prof. Sara Fuchs of the Institute's Immunology Department.

The team includes graduate students Dora Barchan and Sin-Hyeog Im, and Prof. Miriam Souroujon of The Open University in Tel Aviv.

Myasthenia gravis is an autoimmune disease in which the body's immune system mistakenly attacks the receptors in muscles that pick up acetylcholine, a chemical messenger that transmits signals from nerves to muscles. As these acetylcholine receptors are blocked by antibodies and progressively destroyed, the nerve-muscle communication is disrupted and the patient develops weakness in the muscles of the face, throat and limbs. In severe cases, paralysis of respiratory muscles can be life-threatening.

Currently, many patients with myasthenia gravis are given corticosteroid drugs that suppress the immune system, but these drugs may have undesirable side effects. An ideal treatment would suppress only the immune mechanism that goes awry in myasthenia gravis, without affecting the rest of the immune system.

For more than 20 years, Prof. Fuchs has worked with the animal model for myasthenia gravis, attempting to develop a treatment that would be specific for this disease.

In the study reported in PNAS, Fuchs's team genetically engineered a fragment of the human acetylcholine receptor -- the part of the receptor molecule that protrudes above the surface of muscle cells and reacts with various antibodies res

Contact: Jeffrey J. Sussman
American Committee for the Weizmann Institute of Science

Page: 1 2

Related medicine news :

1. Weizmann Institute receives $8 million grant from Flight Attendant Medical Research Institute
2. Weizmann Institute Prof. Moshe Oren named winner of NIH MERIT Award
3. Weizmann Women & Science Award to be presented to Dr. Carla J. Shatz; Millennial Lifetime Achievement Award to Dr. Mildred S. Dresselhaus
4. Gladstone Institutes rank high in the scientist survey of best places for postdocs
5. Institute of Medicine advisory: Jan. 12 Briefing on Complementary and Alternative Medicine
6. Research by scientists affiliated with the Earth Institute at Columbia University
7. New Jersey Institute of Technology pioneers new way to teach engineers
8. Hopkins Institute for Global Tobacco Control receives elite recognition from PAHO/WHO
9. Six new Roybal Centers for Applied Gerontology established by National Institute on Aging
10. American College of Chest Physicians announces new Critical Care Institute
11. UGA professor receives $3 million grant from National Cancer Institute for breast cancer research

Post Your Comments:

(Date:10/13/2017)... ... 2017 , ... As health professionals work to improve their approach to healthcare, ... doing more than filling out a survey; in many cases health professionals and patients ... health care and research on the importance of active engagement with patients and members ...
(Date:10/13/2017)... ... October 13, 2017 , ... The International Association of Eating ... excellence for the field of eating disorders, announces the opening of early registration ... Orlando, Florida at the Omni Resort at ChampionsGate. , The annual ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Lori R. Somekh, ... member of ElderCounsel, a national organization of elder law and special needs planning attorneys. ... and rules. It also provides a forum to network with elder law attorneys nationwide,” ...
(Date:10/13/2017)... RIDGE, N.J. (PRWEB) , ... October 13, 2017 , ... ... annual Holly Day Market. Featuring a collection of specialty vendors and unique items from ... of personalized and quality-focused health and wellness services offered by the VNA. The ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and ... explains one of the most popular and least understood books in the Holy Scriptures, ... puzzling descriptions that have baffled scholars for centuries. Many have tossed it off as ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)...  Eli Lilly and Company (NYSE: LLY ... quarter of 2017 on Tuesday, October 24, 2017. Lilly ... with the investment community and media to further detail ... will begin at 9 a.m. Eastern time. Investors, media ... of the conference call through a link that will ...
(Date:9/28/2017)... Sept. 28, 2017 Hill-Rom Holdings, Inc. (NYSE: ... conference call and webcast on Friday, November 3, 2017, ... and ending at approximately 8:30 a.m. (CDT) / 9:30 ... company,s 2017 financial performance and guidance for 2018, Hill-Rom ... to enhance operational performance, and long-range financial outlook through ...
(Date:9/25/2017)... 25, 2017   Montrium , an industry ... today—from the IQPC Trial Master Files & Inspection ... that EastHORN Clinical Services has selected eTMF ... TMF management. EastHORN, a leading European contract research ... increase transparency to enable greater collaboration with sponsors, ...
Breaking Medicine Technology:
Cached News: